Semax vs Selank: Comparing Two Russian-Developed Nootropic Peptides

Search for “Semax vs Selank” and you will find a range of comparisons that often blur the distinction between the two compounds. Both are Russian-developed synthetic peptides, both are studied in neuroscience contexts, and both are sold as research-use-only laboratory chemicals. But they have different origins, different mechanisms, and different research histories.

This guide explains what each peptide is, what the published research shows, how they differ, and what documentation to verify before sourcing.

What Semax is

Semax is a synthetic heptapeptide that is a synthetic analogue of the ACTH(4-10) fragment of adrenocorticotropic hormone (ACTH), built from the ACTH(4-7) sequence plus a Pro-Gly-Pro tail. It was developed in Russia during the 1980s and has been studied extensively in Russian neuroscience research. A 2016 study in Doklady Biological Sciences reported that Semax prevented learning and memory impairment in rats exposed to heavy metals.

The mechanism is distinct from other nootropic peptides. Semax is studied for its effects on neurotrophic factors, particularly brain-derived neurotrophic factor (BDNF), and for its potential neuroprotective properties. The compound has been investigated in stroke recovery, cognitive function, and neuroprotection research contexts.

What Selank is

Selank is a synthetic heptapeptide that is an analog of the endogenous tetrapeptide tuftsin, a naturally occurring immunomodulatory peptide. It was developed in Russia during the 1990s. A 2017 study in Behavioural Neurology examined the anxiety-related effects of Selank, alone and with diazepam, in a rat model of chronic mild stress.

The mechanism is distinct from Semax. Selank is studied for its effects on GABA receptors and the enkephalin system, which are involved in anxiety regulation and mood. The compound has been investigated in anxiety, stress response, and cognitive function research contexts.

A 2017 study in Frontiers in Pharmacology examined how Selank affects the expression of genes involved in GABAergic neurotransmission in a human neuroblastoma cell line. It is a cell-culture study, so it says nothing directly about effects in people.

How they differ

The two peptides differ in several ways.

Neither compound is licensed in the UK. Both are sold as research-use-only laboratory chemicals, not as medicines. The Alta Peptides comparison of Semax and Selank explains the research context for both compounds.

What the research shows for each

Semax research

The Semax literature is dominated by animal models and Russian clinical research. The compound has been studied for its effects on cognitive function, neuroprotection, and stroke recovery. The 2016 Doklady Biological Sciences study reported that Semax prevented heavy-metal-induced learning and memory impairment in rats.

Selank research

The Selank literature is also dominated by animal models and Russian clinical research. The compound has been studied for its anxiolytic properties and its effects on cognitive function. The 2017 cell-culture study reported that Selank altered the expression of genes involved in GABAergic signalling, which is consistent with the GABA-related mechanism researchers are investigating.

Combined research

Some research has examined the two compounds in combination. The rationale is that the two peptides act on different systems, so combining them may produce complementary effects. However, no large randomised controlled trials have evaluated the combination in a clinical setting.

The researcher’s verification checklist

1. Lot-specific certificate of analysis

A certificate of analysis (COA) is only meaningful if it corresponds to the exact lot you are buying. The COA should list the lot number, the testing laboratory, the report ID, the date the sample was received, and the date the results were published.

2. Complete analytical panel

A certificate that lists only “purity: 99%” is incomplete. The useful fields are identity by mass spectrometry, purity by HPLC, measured content, endotoxin, and sterility.

3. Named independent laboratory

The testing laboratory should be identified and should be a different organisation from the supplier.

4. Research-use-only boundary

The listing should not publish dosing, administration, or human-use content. A supplier that maintains the boundary consistently is easier to trust than one that publishes human-use content alongside the RUO label.

How Alta Peptides approaches Semax and Selank documentation

Alta Peptides is a UK-based research peptide supplier that publishes lot-specific documentation for each product configuration. The company’s Semax product page and Selank product page show the documentation format used across the range. The brain and focus category organises the compounds studied in this research area.

Common questions about Semax and Selank

What is the main difference between Semax and Selank?

Semax is a fragment of ACTH studied for cognitive function and neuroprotection. Selank is a tuftsin analog studied for anxiolytic properties and stress response. They operate through different mechanisms and have different research histories.

Are Semax and Selank licensed in the UK?

No. Neither compound has received a marketing authorisation from the MHRA. Both are sold as research-use-only laboratory chemicals, not as medicines.

What does the research show for each?

Both compounds have been studied primarily in animal models and Russian clinical research. The Semax literature focuses on cognitive function and neuroprotection. The Selank literature focuses on anxiety and stress response. Human clinical trial data is limited for both compounds.

What should a Semax or Selank COA show?

A complete COA should report identity by mass spectrometry, purity by HPLC with the method stated, measured content or assay value, endotoxin testing, and sterility testing. It should also include the lot number, the testing laboratory’s name, the report ID, and the dates of sample receipt and result reporting.

How do I verify that a COA is real?

Check that the testing laboratory is named and that the report ID can be cross-referenced. Some laboratories publish verification portals where a report ID can be entered to confirm the document’s authenticity.

What should I do if a supplier’s listing makes health claims?

Treat it as a disqualifying signal. Health claims on a research peptide listing are the exact pattern that regulators have cited in enforcement actions.